The patient's age and gender must be submitted for FibroSure® testing, height and weight are not required.
Patient should be fasting for at least eight hours.
Collect
Gold top tube.
3.5 mL serum, minimum 2 mL serum
Separate serum from cells within two hours of collection.
Unacceptable Conditions
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
Storage/Transport Temperature
Specimen can be stored at room temp or refrigerated at 2°C to 8°C for 72 hours and frozen at -70°C for seven days. Frozen samples are stable for one freeze/thaw cycle.
Notes
Testing sent to LabCorp, please refer to the following web page for additional information:
Ordering Recommendations
NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.
**CPT code is subject to limited coverage policies for many payers and may require an ABN or Patient Consent for Non-Covered Laboratory Services when ordering
The patient's age and gender must be submitted for FibroSure® testing, height and weight are not required.
Patient should be fasting for at least eight hours.
Collect
Gold top tube.
3.5 mL serum, minimum 2 mL serum
Separate serum from cells within two hours of collection.
Unacceptable Conditions
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
Storage/Transport Temperature
Specimen can be stored at room temp or refrigerated at 2°C to 8°C for 72 hours and frozen at -70°C for seven days. Frozen samples are stable for one freeze/thaw cycle.
Notes
Testing sent to LabCorp, please refer to the following web page for additional information:
Ordering
Ordering Recommendations
NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.
**CPT code is subject to limited coverage policies for many payers and may require an ABN or Patient Consent for Non-Covered Laboratory Services when ordering
